NPI: 1255875290 · MILLVILLE, NJ 08332 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/09/2016
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 12/09/2016 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,706 | $365K |
| 2019 | 8,965 | $480K |
| 2020 | 10,268 | $688K |
| 2021 | 12,033 | $571K |
| 2022 | 18,964 | $570K |
| 2023 | 20,041 | $515K |
| 2024 | 6,676 | $301K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,023 | 1,969 | $3.21M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,593 | 885 | $150K |
| J1756 | Injection, iron sucrose, 1 mg | 7,837 | 1,267 | $37K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,152 | 865 | $34K |
| A4657 | Syringe, with or without needle, each | 8,267 | 1,723 | $23K |
| 85041 | 1,438 | 796 | $8K | |
| 85048 | 1,431 | 794 | $8K | |
| 82728 | 556 | 331 | $5K | |
| 83550 | 375 | 271 | $5K | |
| 83540 | 560 | 320 | $5K | |
| 83970 | 1,221 | 618 | $5K | |
| 82108 | 228 | 145 | $2K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,229 | 383 | $86.80 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 146 | 66 | $2.30 |
| OP250 | 6,445 | 145 | $0.14 | |
| G0008 | Administration of influenza virus vaccine | 77 | 48 | $0.00 |
| 90674 | 30 | 26 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 45 | 15 | $0.00 |